Novartis AG/€NOVN
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Novartis AG
Novartis AG is a global healthcare company based in Switzerland, specializing in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products. The company's core business is centered around patented prescription medicines in areas such as oncology, cardiovascular, immunology, neuroscience, and ophthalmology. Formed in 1996 from the merger of Ciba-Geigy and Sandoz, Novartis operates in over 150 countries worldwide. Its strategic positioning is reinforced by significant investments in research and development, supporting a robust pipeline of innovative therapies. The company is headquartered in Basel, Switzerland, and emphasizes its competitive strength through advanced research capabilities and a diverse product portfolio.
Ticker
€NOVN
Sector
Primary listing
XGAT
Employees
75,883
Headquarters
Basel, Switzerland
Website
Novartis AG Metrics
BasicAdvanced
€217B
17.94
€6.28
0.57
€3.65
3.24%
Price and volume
Market cap
€217B
Beta
0.57
52-week high
€114.60
52-week low
€86.43
Average daily volume
7.3K
Dividend rate
€3.65
Financial strength
Current ratio
0.881
Quick ratio
0.583
Long term debt to equity
54.161
Total debt to equity
71.554
Dividend payout ratio (TTM)
54.32%
Interest coverage (TTM)
18.35%
Profitability
EBITDA (TTM)
21,443.749
Gross margin (TTM)
76.25%
Net profit margin (TTM)
25.53%
Operating margin (TTM)
36.29%
Effective tax rate (TTM)
12.40%
Revenue per employee (TTM)
€636,690
Management effectiveness
Return on assets (TTM)
12.13%
Return on equity (TTM)
32.62%
Valuation
Price to earnings (TTM)
17.939
Price to revenue (TTM)
4.545
Price to book
4.52
Price to tangible book (TTM)
-19.53
Price to free cash flow (TTM)
14.942
Free cash flow yield (TTM)
6.69%
Free cash flow per share (TTM)
7.54
Dividend yield (TTM)
3.24%
Forward dividend yield
3.24%
Growth
Revenue change (TTM)
12.88%
Earnings per share change (TTM)
-14.91%
3-year revenue growth (CAGR)
7.00%
10-year revenue growth (CAGR)
1.08%
3-year earnings per share growth (CAGR)
-9.39%
10-year earnings per share growth (CAGR)
-0.19%
3-year dividend per share growth (CAGR)
4.34%
10-year dividend per share growth (CAGR)
3.97%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novartis AG stock?
Novartis AG (NOVN) has a market cap of €217B as of November 16, 2025.
What is the P/E ratio for Novartis AG stock?
The price to earnings (P/E) ratio for Novartis AG (NOVN) stock is 17.94 as of November 16, 2025.
Does Novartis AG stock pay dividends?
Yes, the Novartis AG (NOVN) stock pays dividends to shareholders. As of November 16, 2025, the dividend rate is €3.6508 and the yield is 3.24%. Novartis AG has a payout ratio of 54.32% on a trailing twelve-month basis.
When is the next Novartis AG dividend payment date?
The next Novartis AG (NOVN) dividend payment date is unconfirmed.
What is the beta indicator for Novartis AG?
Novartis AG (NOVN) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.